Trademark: 79067099
Status Date
Sunday, October 21, 2018
Registration Number
4434280
Registration Date
Tuesday, November 19, 2013
Filing Date
Tuesday, October 21, 2008
Published for Opposition
Tuesday, February 7, 2012
Cancellation Date
Sunday, October 21, 2018
1 Scaffold-free and solid phase free chemical and chemical preparations used in tissue and cell-based spheroid cultures for scientific purposes; chemical preparations, namely, collections of biological tissues and cells for scientific purposes; tissue in the nature of biological tissue, namely, blood, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; fixed arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; biological cells prepared into a format for scientific purposes and research for scientific research use; cell culture systems, three-dimensional cell culture system comprising cell clusters and aggregates for scientific research use
5 Scaffold-free or solid phase free pharmaceutical and veterinary preparations used in tissue and cell-based spheroid cultures for the diagnosis and treatment of cancer; collection of biological tissue and cells, namely, surgical tissues and cells intended for the generation of cell clusters and cell aggregates for medical purposes; tissue, namely, surgical tissues, for diagnosis and treatment of cancer and for medical purposes; fibroblasts, foam cells, glial cells, stem cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells for the generation of cell clusters or cell aggregates
35 Compilation and management of computerized databases used for tissue and cell-based spheroid cultures
42 Scientific and technological services and research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; computer diagnostic services; diagnostic testing of humans for medical research purposes; medical research services; medical research in the field of oncology; medical research in the field of disease indications and identification of tumor indications; testing of drugs, biological and chemical preparations for medical research purposes; pharmaceutical research, inspection and development; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials concerning biological and chemical preparations and pharmaceuticals; medical and scientific research, namely, researching profiles of biological and chemical preparations, pharmaceuticals, antigens; testing for scientific and medical research purposes of combinations of biological and chemical preparations and pharmaceuticals; testing for medical research purposes to determine the chemo-resistance and chemo-sensitivity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the efficacy and toxicity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the effects of biological and chemical preparations and pharmaceuticals on cell toxicity levels; medical research in the nature of pharmacokinetic testing of biological and chemical substances and known pharmaceuticals; medical research concerning the absorption, delivery, metabolism, excretion and toxicity testing of biological and chemical preparations and pharmaceuticals ; medical and scientific research in the field of pharmaceuticals, genetic changes induced by biological or chemical preparations or pharmaceuticals, and pharmaceutical dosing levels; research and development of pharmaceutical treatment therapies for others; scientific research concerning tumour biology, progression and metastasis; medical research concerning optimal treatment and therapy regimes for individuals; medical research concerning optimal cancer therapy for individuals; research and development of new products for others in relation to prediction of cancer therapy; scientific and medical research in the field of radiotherapy; research, development and design of new radiotherapy products for others; scientific and medical research in the field of radiochemotherapy; research, development and design of new products for others in the field of radiochemotherapy; scientific and medical research in the field of stem cells and biomarker discovery, characterization and development; medical research in the fields of ex-vivo therapies, patient material profiling, tumor profiling, in vitro modeling of tissue and biological systems, cell culture systems, three-dimensional cell culture systems, and three-dimensional culture of donor and patient cells; laboratory research services, namely, isolation, culture and treatment of donor and patient tissues and cells for medical research purposes; research laboratory services, namely, preparation of cell lines, primary tissues and fluids, and biological material into a format for scientific and medical research purposes; medical research concerning immunohistology, immunohistology preparation and investigation;Opposition No. 912064346research laboratory services, namely, creation and preparation of biological material into or onto a format for immunohistology investigation, creation and preparation of biological material on a solid or wax support, preparation of sections or slices of biological material on to slides, all for medical research purposes; medical research concerning small molecule development, preparation and generation, antibody research, development, preparation and generation, and vaccine research, development, preparation and generation; provision of information and data relating to scientific and technological research and development; provision of information and data relating to medical and veterinary research and development; provision of information and data relating to scientific and medical research concerning pharmaceuticals, drug testing, drug discovery and development, and testing of biological material; all of the aforementioned services relating to or using tissue and cell-based spheroids cultures
44 Medical and veterinary services; medical diagnostic testing services; medical diagnostic testing services of humans; medical diagnostic and clinical testing services; medical and clinical oncology diagnostic testing services for humans; medical diagnostic testing services in the field of oncology; performing diagnosis of disease indications, performing diagnosis of tumour disease indications; medical screening services for drugs, biological and chemical entities and potential and known pharmaceuticals; medical services, namely, medical testing for and identifying antigens and providing drug therapy for inhibiting antigens; providing individualizing cancer therapy services; providing medical diagnostic services for cancer therapy; medical services, namely, personalized cancer therapy; medical services, namely, radiotherapy; medical services, namely, radiochemotherapy; medical services, namely, preparations of ex-vivo therapies; all relating to medical and veterinary fields; all of the aforementioned services relating to or using tissue and cell-based spheroids cultures
Color is not claimed as a feature of the mark.
SPHERO TECH
May 24, 2019
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
May 24, 2019
Death Of International Registration
Nov 19, 2018
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 6, 2014
Final Decision Transaction Processed By Ib
Feb 19, 2014
Final Disposition Notice Sent To Ib
Feb 19, 2014
Final Disposition Processed
Feb 19, 2014
Final Disposition Notice Created, To Be Sent To Ib
Nov 19, 2013
Registered-Principal Register
Oct 16, 2013
Ttab Release Case To Trademarks
Oct 16, 2013
Opposition Terminated No. 999999
Oct 16, 2013
Opposition Dismissed No. 999999
Sep 23, 2013
Paper Received
Feb 8, 2013
Assigned To Examiner
Sep 8, 2012
Refusal Processed By Ib
Aug 7, 2012
Opposition Instituted No. 999999
Aug 6, 2012
Opposition Notice (Ib Refusal) Sent To Ib
Aug 4, 2012
Opposition Notice (Ib Refusal) Created
Feb 23, 2012
Extension Of Time To Oppose Received
Feb 7, 2012
Published For Opposition
Feb 3, 2012
Notification Of Possible Opposition - Processed By Ib
Jan 26, 2012
Teas Change Of Correspondence Received
Jan 18, 2012
Notification Of Possible Opposition Sent To Ib
Jan 18, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 18, 2012
Notice Of Publication
Jan 3, 2012
Examiners Amendment Mailed
Dec 31, 2011
Law Office Publication Review Completed
Dec 30, 2011
Approved For Pub - Principal Register
Dec 30, 2011
Examiner's Amendment Entered
Dec 30, 2011
Examiners Amendment -Written
Dec 30, 2011
Previous Allowance Count Withdrawn
Nov 22, 2011
Approved For Pub - Principal Register
Oct 18, 2011
Lie Checked Susp - To Atty For Action
Apr 18, 2011
Report Completed Suspension Check Case Still Suspended
Oct 18, 2010
Report Completed Suspension Check Case Still Suspended
Oct 9, 2010
Notification Of Possible Opposition - Processed By Ib
Sep 23, 2010
Notification Of Possible Opposition Sent To Ib
Sep 23, 2010
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 16, 2010
Report Completed Suspension Check Case Still Suspended
Apr 16, 2010
Assigned To Lie
Oct 16, 2009
Letter Of Suspension Mailed
Oct 15, 2009
Suspension Letter Written
Sep 28, 2009
Teas/Email Correspondence Entered
Sep 28, 2009
Correspondence Received In Law Office
Sep 28, 2009
Assigned To Lie
Sep 24, 2009
Teas Response To Office Action Received
Sep 23, 2009
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 23, 2009
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 5, 2009
Refusal Processed By Ib
May 11, 2009
Non-Final Action Mailed - Refusal Sent To Ib
May 11, 2009
Refusal Processed By Mpu
May 9, 2009
Non-Final Action (Ib Refusal) Prepared For Review
May 8, 2009
Non-Final Action Written
Apr 28, 2009
Application Filing Receipt Mailed
Apr 24, 2009
Assigned To Examiner
Apr 24, 2009
New Application Office Supplied Data Entered In Tram
Apr 23, 2009
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
